The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway.
复制标题
幽门螺杆菌感染诱导的新型ZEB1上调蛋白PRTG通过cGMP/PKG信号通路促进胃癌发生。
DOI:
10.1038/s41419-021-03440-1
复制
发表时间:
2021-02-04
影响因子:
9
通讯作者:
Liu G
中科院分区:
文献类型:
--
作者:
Xiang T;Yuan C;Guo X;Wang H;Cai Q;Xiang Y;Luo W;Liu G
Helicobacter pylori (H. pylori) is listed as a class I carcinogen in human gastric cancer; however, the underlying mechanisms are poorly understood. In this study, we identified Protogenin (PRTG) was upregulated in both gastric cancer tissues and H. pylori-infected tissues by analyzing dysregulated genes in TCGA and GEO databases. Importantly, upregulated PRTG predicted poor prognosis of gastric cancer patients and integrative analysis revealed that PRTG served as an oncogenic protein in gastric cancer and was required for H. pylori-mediated tumorigenic activities in in vitro cellular and in vivo tumor-bearing mouse models. Mechanistically, H. pylori infection enhanced PRTG expression by promoting transcriptional factor ZEB1 stabilization and recruitment to the PRTG promoter, and which then activated the sub-following cGMP/PKG signaling pathway in bioinformatic and cellular studies. Cellular studies further confirmed that PRTG depended on activating cGMP/PKG axis to promote proliferation, metastasis, and chemoresistance of gastric cancer cells. The PKG inhibitor KT5823 played synergistic anti-tumor effects with cisplatin and paclitaxel to gastric cancer cells in in vitro cellular and in vivo tumor-bearing mouse models. Taken together, our findings suggested that H. pylori infection depends on ZEB1 to induce PRTG upregulation, and which leading to the development and progression of gastric cancer through activating cGMP/PKG signaling pathway. Blocking PRTG/cGMP/PKG axis, therefore, presents a promising novel therapeutic strategy for gastric cancer.
登录
查看更多内容
影响因子:
4
作者:
Tang XL;Ding BX;Hua Y;Chen H;Wu T;Chen ZQ;Yuan CH
通讯作者:
Yuan CH
影响因子:
16.6
作者:
Kang MH;Choi H;Oshima M;Cheong JH;Kim S;Lee JH;Park YS;Choi HS;Kweon MN;Pack CG;Lee JS;Mills GB;Myung SJ;Park YY
通讯作者:
Park YY
影响因子:
9.7
作者:
Tuttle TR;Mierzwa ML;Wells SI;Fox SR;Ben-Jonathan N
通讯作者:
Ben-Jonathan N
影响因子:
7.3
作者:
Kang, Dong Woo;Yang, Eun Sun;Min, Do Sik
通讯作者:
Min, Do Sik
影响因子:
3.7
作者:
Baud, Jessica;Varon, Christine;Staedel, Cathy
通讯作者:
Staedel, Cathy